ArticlePediatrics2018
Provider Perspectives on Use of Medical Marijuana in Children With Cancer.
Article in Pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 66 citations in OpenAlex.
- A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019.Medical cannabis and cannabinoids · 2021Pooled it
- Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis - A systematic review.PloS one · 2019Pooled it
- Doctors' and pharmacists' perspectives on the clinical use of medicinal Cannabis: a cross-sectional study.Harm reduction journal · 2025Article
- School Nurse Perspectives of Medical Cannabis Policy in K-12 Schools: An Exploratory Descriptive Study.The Journal of school nursing : the official publication of the National Association of School Nurses · 2024Article
- Knowledge, perception, and beliefs of Saudi physicians at King Abdulaziz Medical City, Riyadh related to medical cannabis: Literature review and a cross-sectional survey.Journal of family medicine and primary care · 2023Article
- Perceived Effectiveness of Medical Cannabis Among Adults with Chronic Pain: Findings from Interview Data in a Three-Month Pilot Study.Cannabis (Albuquerque, N.M.) · 2023Article
- Self-perceived knowledge, attitudes, and training needs regarding medical cannabis among health care providers and health volunteers in district health systems, Phitsanulok Province.BMC primary care · 2022Article
- The cannabidiol and marijuana research expansion act: Promotion of scientific knowledge to prevent a national health crisis.Lancet regional health. Americas · 2022Review
- Exploring the medical cannabis prescribing behaviours of New Zealand physicians.Drug and alcohol review · 2022Article
- Perspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer.Cancer reports (Hoboken, N.J.) · 2022Article
- Clinician Beliefs and Practices Related to Cannabis.Cannabis and cannabinoid research · 2022Article
- Exploratory Factor Analysis of Medical Students' Perceptions of Medical Cannabis Scale.Cureus · 2022Article
- Article
- Medical Cannabis in Pediatric Oncology: Friend or Foe?Pharmaceuticals (Basel, Switzerland) · 2022Review
- Palliative Care in Pediatric Oncology and Hematopoietic Stem Cell Transplantation.Current oncology reports · 2022Review
- Medical cannabis in pediatric oncology: a survey of patients and caregivers.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
- Article
- A systematic review of medical students' and professionals' attitudes and knowledge regarding medical cannabis.Journal of cannabis research · 2021Review
- United States oncologists' clinical preferences regarding modes of medicinal cannabis use.Cancer communications (London, England) · 2021Article
- Priorities for Medical Marijuana Research from the Perspective of Physicians, Dispensary Owners/Staff, and Patients: A Survey Study.Medical cannabis and cannabinoids · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 7 institutions in 1 country.
Funding
Abstract
backgroundAlthough medical marijuana (MM) may have utility in the supportive care of children with serious illness, it remains controversial. We investigated interdisciplinary provider perspectives on legal MM use in children with cancer.
methodsWe sent a 32-item, cross-sectional survey to 654 pediatric oncology providers in Illinois, Massachusetts, and Washington characterizing MM practices, knowledge, attitudes, and barriers. Forty-eight percent responded; 44% (
resultsThe provider median age was 35 years (range 22-70 years); 33% were ETC (83 physicians; 13 Washington state advance practice providers). Thirty percent of providers received ≥1 request for MM in the previous month. Notably, only 5% of all providers knew state-specific regulations. ETC providers were more likely to know that MM is against federal laws (
conclusionsMost pediatric oncology providers are willing to consider MM use in children with cancer and receive frequent inquiries. However, ETC providers endorse less favorable attitudes overall. The absence of standards is an important barrier to recommending MM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.